-
1821
Review of the Structural and Dynamic Mechanisms of PPARγ Partial Agonism
Published 2015-01-01“…While endogenous ligands of PPARγ include fatty acids and eicosanoids, synthetic full agonists of the receptor, including members of the thiazolidinedione (TZD) class, have been widely prescribed for the treatment of type II diabetes mellitus (T2DM). Unfortunately, the use of full agonists has been hampered by harsh side effects with some removed from the market in many countries. …”
Get full text
Article -
1822
Along for the Ride: Intrahepatic Cholangiocarcinoma with Concomitant LECT2 Amyloidosis
Published 2020-01-01“…We present a case of a 69-year-old Hispanic male with a past medical history of type II diabetes mellitus who presented with a two-month history of abdominal pain. …”
Get full text
Article -
1823
Gender Differences in Metabolic Disorders and Related Diseases in Spontaneously Diabetic Torii-Leprfa Rats
Published 2014-01-01“…The Spontaneously Diabetic Torii Leprfa (SDT fatty) rat is a novel type 2 diabetic model wherein both male and female rats develop glucose and lipid abnormalities from a young age. …”
Get full text
Article -
1824
Tribbles 3 Regulates the Fibrosis Cytokine TGF-β1 through ERK1/2-MAPK Signaling Pathway in Diabetic Nephropathy
Published 2014-01-01“…To reveal the expression and possible role of tribbles homolog 3 (TRB3) in the incidence of type 2 diabetic nephropathy, we used immunohistochemistry, real-time quantitative PCR, western blot analysis, and enzyme-linked immunosorbent assay (ELISA) to study the expression of TRB3, extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase (ERK1/2 MAPK), transforming growth factor β1 (TGF-β1), and collagen type IV in kidneys of db/db diabetic mice and in murine renal mesangial cells stimulated with high glucose. …”
Get full text
Article -
1825
The Role of PPARγ in the Transcriptional Control by Agonists and Antagonists
Published 2012-01-01“…In recent years, peroxisome proliferator-activated receptor gamma (PPARγ) has been reported to be a target for the treatment of type II diabetes. Furthermore, it has received attention for its therapeutic potential in many other human diseases, including atherosclerosis, obesity, and cancers. …”
Get full text
Article -
1826
Risk Factors for Microvascular Complications of Diabetes in a High-Risk Middle East Population
Published 2018-01-01“…We collected information via a structured questionnaire and directly from the patient’s record on 1034 adult type 2 diabetic patients who were attending outpatient clinics in Qatar. …”
Get full text
Article -
1827
A Molecular and Whole Body Insight of the Mechanisms Surrounding Glucose Disposal and Insulin Resistance with Hypoxic Treatment in Skeletal Muscle
Published 2016-01-01“…In addition, hypoxic exposure has been shown to improve glucose control in type 2 diabetics. The literature surrounding hypoxia-induced changes to glycemic control appears to be confusing and conflicting. …”
Get full text
Article -
1828
Signaling Pathway Puts the Break on Fat Cell Formation
Published 2001-01-01“…Unfortunately, excess fat or adipose tissue is associated with a wide array of health problems, including increased incidence of type II diabetes, cardiovascular disease, hypertension, sleep apnea, and skeletomuscular problems [4,5,6]. …”
Get full text
Article -
1829
Serum Fibroblast Growth Factor 21 Levels Are Correlated with the Severity of Diabetic Retinopathy
Published 2014-01-01“…The aim of the study was to assess serum fibroblast growth factor 21 (FGF21) concentrations in Chinese type 2 diabetic patients with and without retinopathy and to assess the association between FGF21 and the severity of retinopathy. 117 diabetic patients were compared with 68 healthy controls. …”
Get full text
Article -
1830
Density functional theory and molecular dynamics simulation-based bioprospection of Agathosma betulina essential oil metabolites against protein tyrosine phosphatase 1B for interve...
Published 2025-02-01“…Type II diabetes mellitus (T2DM) is characterized by elevated blood glucose due to impaired insulin secretion/sensitivity. …”
Get full text
Article -
1831
Anti-diabetic effect of aloin via JNK-IRS1/PI3K pathways and regulation of gut microbiota
Published 2022-01-01“…The insulin-resistant HepG2 (IR-HepG2) cell model and the type 2 diabetic (T2D) mouse model were successfully established using dexamethasone and a high-fat high-sucrose diet with low-dose streptozotocin, respectively. …”
Get full text
Article -
1832
Regulation of Glial Cell Functions by PPAR-𝜸 Natural and Synthetic Agonists
Published 2008-01-01“…In the recent years, the peroxisome proliferator-activated receptor-𝛾 (PPAR-𝛾), a well known target for type II diabetes treatment, has received an increasing attention for its therapeutic potential in inflammatory and degenerative brain disorders. …”
Get full text
Article -
1833
The Association of Adiposity Indices and Plasma Vitamin D in Young Females in Saudi Arabia
Published 2016-01-01“…Some evidences indicate its association with metabolic syndrome, type II diabetes, and cardiovascular diseases. In the current study we aim to study the association of vitamin D level and indicators of adiposity in young Saudi females. …”
Get full text
Article -
1834
Effect of Dietary Content of Menhaden Oil with or without Salsalate on Neuropathic Endpoints in High-Fat-Fed/Low-Dose Streptozotocin-Treated Sprague Dawley Rats
Published 2018-01-01“…In this study, we wanted to extend our investigation of the efficacy of fish oil with or without salsalate on vascular and neural complications using a type 2 diabetic rat model. Four weeks after the onset of hyperglycemia, diabetic rats were treated via the diet with 3 different amounts of menhaden oil with or without salsalate for 12 weeks. …”
Get full text
Article -
1835
Reducing oxidative stress and hepatoprotective effect of water extracts from Pu-erh tea on rats with high-fat diet
Published 2016-12-01“…Meanwhile, the extracts could increase the production of hepatic glycogen and the activity of PK, and reduce glucose level, protecting the liver from the diseases associated with type II diabetes.…”
Get full text
Article -
1836
Evaluation of the EndoPAT as a Tool to Assess Endothelial Function
Published 2012-01-01“…Endothelial function in renally impaired and type 2 diabetic patients was not decreased compared to healthy volunteers (2.9±1.4 and 1.8±0.3, resp., versus 1.8±0.5, P>0.05). …”
Get full text
Article -
1837
Influence of Duodenal–Jejunal Implantation on Glucose Dynamics: A Pilot Study Using Different Nonlinear Methods
Published 2019-01-01“…We hypothesized that DJBL also influences the glucose dynamics in type II diabetes, based on the induced changes already demonstrated in other physiological characteristics and parameters. …”
Get full text
Article -
1838
Proinflammatory Cytokine Expression in Apical Periodontitis from Diabetic Patients
Published 2023-01-01“…Therefore, this study evaluated the immunoexpression of IL-1β, TNF-α, and IL-17 in apical periodontitis from type 2 diabetic patients through immunohistochemistry. …”
Get full text
Article -
1839
Atypical Presentation of Disseminated Zoster in a Patient with Rheumatoid Arthritis
Published 2015-01-01“…Comorbidities include hypertension, type II diabetes, and dyslipidemia. Patient was on methotrexate 12.5 mg and was not receiving any corticosteroids, anti-TNF therapy, or other biological agents. …”
Get full text
Article -
1840
Insulin Therapy in Diabetic Hyperglycemic Emergencies
Published 2014-09-01“…<br /><strong>Results:</strong> diabetic ketoacidosis occurred in 57.5 % of the type 1 diabetic patients and in the 42.5 % of the type 2 diabetics. None of the type 1 diabetics developed hyperglycemic hyperosmolar nonketotic state and this complication was observed in 23.0 % of the patients with diabetes type 2. …”
Get full text
Article